First-in-human Safety and Tolerability of MP0317 in Patients With Relapsed/Refractory Advanced Solid Tumors
Clinical trial NCT05098405 · TERMINATED
Trial details
- NCT number
- NCT05098405
- Sponsor
- Molecular Partners AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-11
- Primary completion
- 2024-01-19
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.